Neuralstem Inc.

Neuralstem Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.35
Market Cap
$6.26 M
Shares Outstanding
20.01 M
Public Float
17.89 M

Profile

Address
20271 Goldenrod Lane
Germantown Maryland 20876
United States
Employees -
Website http://www.neuralstem.com
Updated 07/08/2019
Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I.

Financials

View All
Created with Highcharts 5.0.14Neuralstem Inc.Net Income. Fiscal year is January-December. All values USD Thousands.19 83119 83122 62822 62820 90320 90321 07421 07415 66615 6664 9244 92420132014201520162017201805k10k15k20k25k
Created with Highcharts 5.0.14Neuralstem Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.110110181810101616260260260260201320142015201620172018050100150200250300

William Clyde Oldaker
Chairman
Xi Chen
Director